<h3>Gainers</h3>
<ul>
<li>Polaryx Therapeutics (NASDAQ:PLYX) shares increased by 80.9% to $4.36 during Tuesday's regular session. The company's market cap stands at $114.0 million. </li>
<li>Baird Medical Investment (NASDAQ:BDMD) stock increased by 45.25% to $1.12. The company's market cap stands at $28.2 million. </li>
<li>Compass Pathways (NASDAQ:CMPS) stock increased by 42.42% to $8.28. The market value of their outstanding shares is at $543.5 million. </li>
<li>Masimo (NASDAQ:MASI) shares moved upwards by 34.4% to $174.93. The market value of their outstanding shares is at $7.0 billion. </li>
<li>Ensysce Biosciences (NASDAQ:ENSC) shares increased by 28.68% to $0.56. The company's market cap stands at $1.5 million. </li>
<li>Biodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 21.75% to $1.31. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Liminatus Pharma (NASDAQ:LIMN) shares fell 33.9% to $0.25 during Tuesday's regular session. The company's market cap stands at $10.1 million. </li>
<li>Ocular Therapeutix (NASDAQ:OCUL) shares decreased by 24.84% to $6.67. The market value of their outstanding shares is at $1.9 billion. </li>
<li>Mainz Biomed (NASDAQ:MYNZ) shares fell 22.67% to $0.62. The company's market cap stands at $6.8 million. </li>
<li>Strata Skin Sciences (NASDAQ:SSKN) stock fell 18.25% to $0.28. The market value of their outstanding shares is at $2.0 million. </li>
<li>Quince Therapeutics (NASDAQ:QNCX) shares declined by 15.06% to $0.17. The company's market cap stands at $11.1 million. </li>
<li>Solid Biosciences (NASDAQ:SLDB) shares fell 14.22% to $5.31. The market value of their outstanding shares is at $482.0 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LIMN

IBBQ

In Tuesday's intraday session, Polaryx Therapeutics (PLYX) saw a significant gain of 80.9%, reaching $4.36, with a market cap of $114 million. Other notable gainers included Baird Medical Investment (BDMD) up 45.25%, Compass Pathways (CMPS) up 42.42%, and Masimo (MASI) up 34.4%. Conversely, Liminatus Pharma (LIMN) experienced the largest drop, falling 33.9% to $0.25. Other losers included Ocular Therapeutix (OCUL) down 24.84% and Mainz Biomed (MYNZ) down 22.67%.

benzinga_article

Liminatus Pharma

Invesco Nasdaq Biotechnology ETF

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

Mainz Biomed NV

iShares Biotechnology ETF

Polaryx Therapeutics

iShares Global Healthcare

SPDR S&P Health Equip

Masimo

First Trust NYSE Arca Biotech Index Fd

Compass Pathways

VG Health

iShares US Pharma

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

VanEck Biotech ETF

Ark Genomic Revolution ETF

Health Care Select Sector SPDR

iShares US Medical Devices

Ocular Therap

Baird Medical Investment

12 Health Care Stocks Moving In Tuesday's Intraday Session